The pre-supplementary motor area achieves inhibitory control by modulating response thresholds
dc.contributor.author | Wolpe, Noham | |
dc.contributor.author | Hezemans, Frank H | |
dc.contributor.author | Rae, Charlotte | |
dc.contributor.author | Zhang, Jiaxiang | |
dc.contributor.author | Rowe, James | |
dc.date.accessioned | 2022-03-26T00:30:11Z | |
dc.date.available | 2022-03-26T00:30:11Z | |
dc.date.issued | 2022-07 | |
dc.identifier.issn | 0010-9452 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/335346 | |
dc.description.abstract | The pre-supplementary motor area (pre-SMA) is central for the initiation and inhibition of voluntary action. For the execution of action, the pre-SMA optimises the decision of which action to choose by adjusting the thresholds for the required evidence for each choice. However, it remains unclear how the pre-SMA contributes to action inhibition. Here, we use computational modelling of a stop/no-go task, performed by an adult with a focal lesion in the pre-SMA, and 52 age-matched controls. We show that the patient required more time to successfully inhibit an action (longer stop-signal reaction time) but was faster in terms of go reaction times. Computational modelling revealed that the patient’s failure to stop was explained by a significantly lower response threshold for initiating an action, as compared to controls, suggesting that the patient needed less evidence before committing to an action. A similarly specific impairment was also observed for the decision of which action to choose. Together, our results suggest that dynamic threshold modulation may be a general mechanism by which the pre-SMA exerts its control over voluntary action. | |
dc.publisher | Elsevier | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.title | The pre-supplementary motor area achieves inhibitory control by modulating response thresholds | |
dc.type | Article | |
dc.publisher.department | Department of Clinical Neurosciences | |
dc.date.updated | 2022-03-23T13:39:59Z | |
prism.publicationName | Cortex | |
dc.identifier.doi | 10.17863/CAM.82778 | |
dcterms.dateAccepted | 2022-03-19 | |
rioxxterms.versionofrecord | 10.1016/j.cortex.2022.03.018 | |
rioxxterms.version | AM | |
dc.contributor.orcid | Rowe, James [0000-0001-7216-8679] | |
dc.identifier.eissn | 1973-8102 | |
rioxxterms.type | Journal Article/Review | |
pubs.funder-project-id | Wellcome Trust (103838/Z/14/Z) | |
pubs.funder-project-id | Medical Research Council (MC_UU_00005/12) | |
cam.orpheus.success | Wed May 25 11:13:26 BST 2022 - Embargo updated | |
cam.orpheus.counter | 3 | |
cam.depositDate | 2022-03-23 | |
pubs.licence-identifier | apollo-deposit-licence-2-1 | |
pubs.licence-display-name | Apollo Repository Deposit Licence Agreement | |
rioxxterms.freetoread.startdate | 2023-04-14 |
Files in this item
This item appears in the following Collection(s)
-
Cambridge University Research Outputs
Research outputs of the University of Cambridge